Skip to main content
SpringerLink
Log in
Book cover

Clinical and Basic Immunodermatology pp 193–206Cite as

Atopic Dermatitis

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113(5):832–6.

    Article  PubMed  CAS  Google Scholar 

  2. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003;112(2):252–62.

    Article  PubMed  Google Scholar 

  3. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368(9537):733–43.

    Article  PubMed  Google Scholar 

  4. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299(6710):1259–60.

    PubMed  CAS  Google Scholar 

  5. Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006;118(1):209–13.

    Article  PubMed  Google Scholar 

  6. Schultz Larsen FV, Holm NV. Atopic dermatitis in a population based twin series. Concordance rates and heritability estimation. Acta Derm Venereol Suppl (Stockh) 1985;114:159.

    CAS  Google Scholar 

  7. Cookson WO, Ubhi B, Lawrence R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27(4):372–3.

    Article  PubMed  CAS  Google Scholar 

  8. Bradley M, Soderhall C, Luthman H, Wahlgren CF, Kockum I, Nordenskjold M. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 2002;11(13):1539–48.

    Article  PubMed  CAS  Google Scholar 

  9. Lee YA, Wahn U, Kehrt R, et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000;26(4):470–3.

    Article  PubMed  CAS  Google Scholar 

  10. Forrest S, Dunn K, Elliott K, et al. Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 1999;104(5):1066–70.

    Article  PubMed  CAS  Google Scholar 

  11. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subu-nit of the interleukin-4 receptor. N Engl J Med 1997;337(24):1720–5.

    Article  PubMed  CAS  Google Scholar 

  12. Novak N, Kruse S, Kraft S, et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002;119(4):870–5.

    Article  PubMed  CAS  Google Scholar 

  13. Novak N, Kruse S, Potreck J, et al. Single nucle-otide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol 2005;115(4):828–33.

    Article  PubMed  CAS  Google Scholar 

  14. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38(4):441–6.

    Article  PubMed  CAS  Google Scholar 

  15. Weidinger S, Illig T, Baurecht H, et al. Loss-of-func-tion variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006;118(1):214–9.

    Article  PubMed  CAS  Google Scholar 

  16. Morar N, Cookson WO, Harper JI, Moffatt MF. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007.

    Google Scholar 

  17. Barker JN, Palmer CN, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007;127(3):564–7.

    Article  PubMed  CAS  Google Scholar 

  18. Marenholz I, Nickel R, Ruschendorf F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006;118(4):866–71.

    Article  PubMed  CAS  Google Scholar 

  19. c

    Article  PubMed  CAS  Google Scholar 

  20. Vasilopoulos Y, Cork MJ, Murphy R, et al. Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004;123(1):62–6.

    Article  PubMed  CAS  Google Scholar 

  21. Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy 2005;35(10):1301–8.

    Article  PubMed  CAS  Google Scholar 

  22. Peters EM, Raap U, Welker P, et al. Neurotrophins act as neuroendocrine regulators of skin home-ostasis in health and disease. Horm Metab Res 2007;39(2):110–24.

    Article  PubMed  CAS  Google Scholar 

  23. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993;363(6425):159–63.

    Article  PubMed  CAS  Google Scholar 

  24. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147(1):71–9.

    Article  PubMed  CAS  Google Scholar 

  25. Raap U, Kapp A. Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 2005;5(5):419–24.

    PubMed  CAS  Google Scholar 

  26. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006;43(3):159–69.

    Article  PubMed  CAS  Google Scholar 

  27. Sator PG, Schmidt JB, Honigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003;48(3):352–8.

    Article  PubMed  Google Scholar 

  28. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol 2004;5(4):217–23.

    Article  PubMed  Google Scholar 

  29. Izadpanah A, Gallo RL. Antimicrobial peptides. J Am Acad Dermatol 2005;52(3 pt 1):381–90; quiz 391–2.

    Article  PubMed  Google Scholar 

  30. McGirt LY, Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006;118(1):202–8.

    Article  PubMed  CAS  Google Scholar 

  31. Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171(6):3262–9.

    PubMed  CAS  Google Scholar 

  32. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347(15):1151–60.

    Article  PubMed  CAS  Google Scholar 

  33. Rieg S, Steffen H, Seeber S, et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005;174(12):8003–10.

    PubMed  CAS  Google Scholar 

  34. Santamaria-Babi LF. Skin-homing T cells in cutaneous allergic inflammation. Chem Immunol Allergy 2006;91:87–97.

    Article  PubMed  CAS  Google Scholar 

  35. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999;103(8):1103–11.

    Article  PubMed  CAS  Google Scholar 

  36. Reinhold U, Kukel S, Goeden B, Neumann U, Kreysel HW. Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991;86(3):444–8.

    PubMed  CAS  Google Scholar 

  37. Grewe M, Bruijnzeel-Koomen CA, Schopf E, et al. A role for Th1 and Th2 cells in the immun-opathogenesis of atopic dermatitis. Immunol Today 1998;19(8):359–61.

    Article  PubMed  CAS  Google Scholar 

  38. Beissert S, Schwarz A, Schwarz T. Regulatory T cells. J Invest Dermatol 2006;126(1):15–24.

    Article  PubMed  CAS  Google Scholar 

  39. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006;24:209–26.

    Article  PubMed  CAS  Google Scholar 

  40. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of the immune response. Immunol Rev 2005;203:156–64.

    Article  PubMed  CAS  Google Scholar 

  41. Verhagen J, Akdis M, Traidl-Hoffmann C, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006;117(1):176–83.

    Article  PubMed  CAS  Google Scholar 

  42. Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004;113(4):756–63.

    Article  PubMed  CAS  Google Scholar 

  43. Bach JF. Infections and autoimmune diseases. J Autoimmun 2005;25(suppl):74–80.

    Article  PubMed  CAS  Google Scholar 

  44. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006;118(1):178–89.

    Article  PubMed  CAS  Google Scholar 

  45. Biedermann T, Rocken M, Carballido JM. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Invest Dermatol Symp Proc 2004;9(1):5–14.

    Article  CAS  Google Scholar 

  46. Fiset PO, Leung DY, Hamid Q. Immunopathology of atopic dermatitis. J Allergy Clin Immunol 2006;118(1):287–90.

    Article  PubMed  CAS  Google Scholar 

  47. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94(2):870–6.

    Article  PubMed  CAS  Google Scholar 

  48. Kimura M, Tsuruta S, Yoshida T. Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol 1998;101(1 Pt 1):84–9.

    Article  PubMed  CAS  Google Scholar 

  49. Park JH, Choi YL, Namkung JH, et al. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol 2006;155(4):778–83.

    Article  PubMed  Google Scholar 

  50. Toda M, Leung DY, Molet S, et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003;111(4):875–81.

    Article  PubMed  CAS  Google Scholar 

  51. Kim BE, Leung DY, Streib JE, Boguniewicz M, Hamid QA, Howell MD. Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol 2007;119(2):457–63.

    Article  PubMed  CAS  Google Scholar 

  52. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3(7):673–80.

    PubMed  CAS  Google Scholar 

  53. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006;20:203(2):269–73.

    Article  Google Scholar 

  54. Neis MM, Peters B, Dreuw A, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006;118(4):930–7.

    Article  PubMed  CAS  Google Scholar 

  55. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7(1):19–30.

    Article  PubMed  CAS  Google Scholar 

  56. Bieber T, de la Salle H, Wollenberg A, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 1992;175(5):1285–90.

    Article  Google Scholar 

  57. Wollenberg A, Wen SP, Bieber T. Langerhans cell phenotyping—a new tool for differential-diagnosis of inflammatory diseases. Lancet 1995;346(8990):1626–7.

    Article  PubMed  CAS  Google Scholar 

  58. Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996;106(3):446–53.

    Article  PubMed  CAS  Google Scholar 

  59. Novak N, Valenta R, Bohle B, et al. FcεRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 2004;113(5):949–57.

    Article  PubMed  CAS  Google Scholar 

  60. Novak N, Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 2005;53(2 Suppl 2):S171–6.

    Article  PubMed  Google Scholar 

  61. Wollenberg A, Wagner M, Gunther S, et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002;119(5):1096–102.

    Article  PubMed  CAS  Google Scholar 

  62. Hashizume H, Horibe T, Yagi H, Seo N, Takigawa M. Compartmental imbalance and aberrant immune function of blood CD123+ (plasmacytoid) and CD11c+ (myeloid) dendritic cells in atopic dermatitis. J Immunol 2005;174(4):2396–403.

    PubMed  CAS  Google Scholar 

  63. Cardona ID, Cho SH, Leung DY. Role of bacterial superantigens in atopic dermatitis : implications for future therapeutic strategies. Am J Clin Dermatol 2006;7(5):273–9.

    Article  PubMed  Google Scholar 

  64. Howell MD, Gallo RL, Boguniewicz M, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006;24(3):341–8.

    Article  PubMed  CAS  Google Scholar 

  65. Strickland I, Hauk PJ, Trumble AE, Picker LJ, Leung DY. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 1999;112(2):249–53.

    Article  PubMed  CAS  Google Scholar 

  66. Leung DY, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993;92(3):1374–80.

    Article  PubMed  CAS  Google Scholar 

  67. Mittermann I, Aichberger KJ, Bunder R, Mothes N, Renz H, Valenta R. Autoimmunity and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004;4(5):367–71.

    Article  PubMed  CAS  Google Scholar 

  68. Valenta R, Natter S, Seiberler S, et al. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 1998;111(6):1178–83.

    Article  PubMed  CAS  Google Scholar 

  69. Schmid-Grendelmeier P, Fluckiger S, Disch R, et al. IgE-mediated and T cell-mediated autoim-munity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005;115(5):1068–75.

    Article  PubMed  CAS  Google Scholar 

  70. Mothes N, Niggemann B, Jenneck C, et al. The cradle of IgE autoreactivity in atopic eczema lies in early infancy. J Allergy Clin Immunol 2005;116(3):706–9.

    Article  PubMed  CAS  Google Scholar 

  71. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005;352(22):2314–24.

    Article  PubMed  CAS  Google Scholar 

  72. Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003;112(4):667–74.

    Article  PubMed  Google Scholar 

  73. Hanifin J, Rajka G. Diagnostic features of atopic eczema. Acta Derm Venereol 1980;92:44–7.

    Google Scholar 

  74. Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131(3):383–96.

    Article  PubMed  CAS  Google Scholar 

  75. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186(1):23–31.

    Google Scholar 

  76. Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB Jr, Balkrishnan R. Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study. Br J Dermatol 2002;147(6):1192–8.

    Article  PubMed  CAS  Google Scholar 

  77. Ring J, Bieber T, Vieluf D, Kunz B, Przybilla B. Atopic eczema, Langerhans cells and allergy. Int Arch Allergy Appl Immunol 1991;94(1–4): 194–201.

    PubMed  CAS  Google Scholar 

  78. Darsow U, Vieluf D, Ring J. Atopy patch test with different vehicles and allergen concentrations: an approach to standardization. J Allergy Clin Immunol 1995;95(3):677–84.

    Article  PubMed  CAS  Google Scholar 

  79. Morren MA, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994;31 (3 pt 1):467–73.

    Article  PubMed  CAS  Google Scholar 

  80. Callen J, Chamlin S, Eichenfield LF, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 2007;156(2):203–21.

    Article  PubMed  CAS  Google Scholar 

  81. Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994;131(4):536–40.

    Article  PubMed  CAS  Google Scholar 

  82. Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 2002;324(7340):768.

    Article  PubMed  CAS  Google Scholar 

  83. Berth-Jones J, Damstra RJ, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003;326(7403):1367.

    Article  PubMed  CAS  Google Scholar 

  84. Bieber T, Vick K, Folster-Holst R, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007;62(2):184–9.

    Article  PubMed  CAS  Google Scholar 

  85. Alomar A, Berth-Jones J, Bos JD, et al. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 2004;151(suppl 70):3–27.

    Article  PubMed  CAS  Google Scholar 

  86. Breuer K, Werfel T, Kapp A. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol 2005;6(2):65–77.

    Article  PubMed  Google Scholar 

  87. Bieber T, Cork M, Ellis C, et al. Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology 2005;211(2):77–8.

    Article  PubMed  CAS  Google Scholar 

  88. Wohlrab J, Jost G, Abeck D. Antiseptic efficacy of a low-dosed topical triclosan/chlorhexidine combination therapy in atopic dermatitis. Skin Pharmacol Physiol 2006;20(2):71–6.

    Article  PubMed  CAS  Google Scholar 

  89. Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol 1998;139(suppl 53):37–40.

    Article  PubMed  CAS  Google Scholar 

  90. Juenger M, Ladwig A, Staecker S, et al. Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Curr Med Res Opin 2006;22(4):739– 50.

    Article  PubMed  CAS  Google Scholar 

  91. Wahlgren CF, Hagermark O, Bergstrom R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol 1990;122(4):545–51.

    Article  PubMed  CAS  Google Scholar 

  92. Griffiths CE, Katsambas A, Dijkmans BA, et al. Update on the use of cyclosporin in immune-mediated dermatoses. Br J Dermatol 2006;155 (suppl 2):1–16.

    Article  PubMed  CAS  Google Scholar 

  93. Hijnen DJ, ten Berge O, Timmer-de Mik L, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. J Eur Acad Dermatol Venereol 2007;21(1):85–9.

    Article  PubMed  CAS  Google Scholar 

  94. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006;367(9513):839–46.

    Article  PubMed  CAS  Google Scholar 

  95. Meggitt SJ, Reynolds NJ. Azathioprine for atopic dermatitis. Clin Exp Dermatol 2001;26(5):369–75.

    Article  PubMed  CAS  Google Scholar 

  96. Krathen RA, Hsu S. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol 2005;53(2):338–40.

    Article  PubMed  Google Scholar 

  97. Lane JE, Cheyney JM, Lane TN, Kent DE, Cohen DJ. Treatment of recalcitrant atopic dermatitis with omali-zumab. J Am Acad Dermatol 2006;54(1):68–72.

    Article  PubMed  Google Scholar 

  98. Takiguchi R, Tofte S, Simpson B, et al. Efalizumab for severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol 2007;56(2):222–7.

    Article  PubMed  Google Scholar 

  99. Cassano N, Loconsole F, Coviello C, Vena GA. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int J Immunopathol Pharmacol 2006;19(1):237–40.

    PubMed  CAS  Google Scholar 

  100. Jacobi A, Antoni C, Manger B, Schuler G, Hertl M. Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2005;52(3 pt 1):522–6.

    Article  PubMed  Google Scholar 

  101. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003;148(4):626–37.

    Article  PubMed  CAS  Google Scholar 

  102. Tzaneva S, Seeber A, Schwaiger M, Honigsmann H, Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001;45(4):503–7.

    Article  PubMed  CAS  Google Scholar 

  103. Silva SH, Guedes AC, Gontijo B, et al. Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis. J Eur Acad Dermatol Venereol 2006;20(9):1114–20.

    Article  PubMed  CAS  Google Scholar 

  104. Werfel T, Breuer K, Rueff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006;61(2):202–5.

    Article  PubMed  CAS  Google Scholar 

  105. Bussmann C, Bockenhoff A, Henke H, Werfel T, Novak N. Does allergen-specific immuno-therapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006;118(6):1292–8.

    Article  PubMed  CAS  Google Scholar 

  106. Staab D, Diepgen TL, Fartasch M, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006;332(7547):933–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Allergy, Friedrich Wilhelms University, Bonn, Germany

    Thomas Bieber & Julia Prölss

Authors
  1. Thomas Bieber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julia Prölss
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA

    Anthony A. Gaspari MD

  2. Department of Dermatology, University of Texas Medical School at Houston, Houston, TX, USA

    Stephen K. Tyring MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Bieber, T., Prölss, J. (2008). Atopic Dermatitis. In: Gaspari, A.A., Tyring, S.K. (eds) Clinical and Basic Immunodermatology. Springer, London. https://doi.org/10.1007/978-1-84800-165-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-165-7_13

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-164-0

  • Online ISBN: 978-1-84800-165-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation